Metagenomi, Inc. Common Stock (MGX)
Healthcare
Biotechnology
1.20 $
+1.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Metagenomi, Inc. Common Stock (MGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -89 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 24 | 30 | -91 | -109 | -89 | |
| 0.4 | 1.7 | 4.2 | 5.4 | 5.3 | |
| 0.4 | 2.0 | 6.9 | 16 | 12 | |
| 46 | 69 | -26 | -60 | -22 | |
| 2.9 | 14 | 9.8 | 3.1 | 0.6 | |
| -74 | -122 | 46 | -88 | 104 | |
| 30 | 0.0 | – | – | – | |
| 40 | 240 | 1.0 | 84 | -0.4 | |
| -10 | 147 | -45 | -113 | 14 | |
| 21 | 16 | -101 | -112 | -89 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.